Pharmacokinetics and bioavailability of a new slow-release isosorbide-5-mononitrate system
Gandini, R.; Cunietti, E.; Assereto, R.; Castoldi, D.; Tofanetti, O.; Baggio, E.
Cardiologia 32(11): 1287-1291
1987
ISSN/ISBN: 0393-1978 PMID: 3447701 Document Number: 293009
Document emailed within 1 workday
Related Documents
Cleophas, T.J.; Niemeyer, M.G.; Zwinderman, A.H.; van der Wall, E.E. 2000: Isosorbide mononitrate 30% immediate-release 70% sustained-release formulation: a review. DUMQOL (DUtch Mononitrate Quality of Life) Study Group Angiology 51(8): 631-638Richard, L.; Klein, G.; Orr, J.M. 1976: Simultaneous measurement of plasma isosorbide dinitrate, isosorbide-2-mononitrate, and isosorbide-5-mononitrate by gas-liquid chromatography Clinical Chemistry 22(12): 2060-2061
Atanassova, R.; Balansky, R. 1991: Effects of isosorbide-5-mononitrate and isosorbide-2-mononitrate on isolated dog aorta: vascular relaxation and increase in cyclic GMP Archives Internationales de Pharmacodynamie et de Therapie 312: 104-109
Centonze, F.; Brambilla, M.; Pittana, P.; Serra, G.; Sega, R. 1988: Comparison of steady state pharmacokinetics of isosorbide-5-mononitrate in microgranular formulation or hydrophilic matrix La Clinica Terapeutica 126(3): 195-206
Schneider, W.; Stahl, B.; Kaltenbach, M.; Bussmann, W.D. 1984: Differences in the production of methemoglobin during high-dose treatment with isosorbide dinitrate or isosorbide 5-mononitrate Arzneimittel-Forschung 34(12): 1779-1782
Lazebnik, L.B.; Tereshchenko, S.N.; Gendel'man, A.M. 1991: Comparison of the clinical and hemodynamic effects of nitroglycerin, isosorbide dinitrate and isosorbide-5-mononitrate in acute myocardial infarction Kardiologiia 31(10): 13-15
Nakabayashi, S.; Uyama, O.; Nagatsuka, K.; Uehara, A.; Wanaka, A.; Yoneda, S.; Kimura, K.; Kamata, T. 1985: The effect of isosorbide dinitrate and isosorbide-5-mononitrate on prostacyclin (PGI2) and thromboxane A2 (TXA2) generation in rat and human arteries Research Communications in Chemical Pathology and Pharmacology 47(3): 323-332
Sizova, Z.M.; Kozlova, N.V.; Zakharova, V.L.; Shameeva, E.S. 2015: Comparative Assessment of Effects of Isosorbide Dinitrate, Isosorbide-5-Mononitrate and Nicorandil on the Frequency-of Angina Attacks and Vasoregulating Endothelial Function in Patients with Ischemic Heart Disease Kardiologiia 55(2): 10-15
Döring, G. 1992: Antianginal and anti-ischemic efficacy of nicorandil in comparison with isosorbide-5-mononitrate and isosorbide dinitrate: results from two multicenter, double-blind, randomized studies with stable coronary heart disease patients Journal of Cardiovascular Pharmacology 20(Suppl 3): S74-S81
Chasseaud, L.F.; Taylor, T.; Major, R.M.; Taylor, I.W.; Luckow, V.; Darragh, A.; Lambe, R.F. 1983: Pharmacokinetics of 14C-isosorbide dinitrate after administration in various sustained-release formulations Arzneimittel-Forschung 33(9): 1298-1301
Kogi, K.; Saito, T. 1985: Effects of isosorbide 5-mononitrate on cardiovascular function. (I). Effects on the left ventricular system Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica 85(5): 335-342
Nyberg, L.; Kennedy, B.M. 1984: Pharmacokinetics of terbutaline given in slow-release tablets European Journal of Respiratory Diseases. Suppl 134: 119-139
Kumar, P.D. 1992: Comparative bioavailability of slow release dicbfenac (Voveran SR) with enteric coated tablet and internationally used Voltaren retard Journal of the Association of Physicians of India 40(7): 483
Simoni, P.; Sabatini, L.; Baraldini, M.; Mirasoli, M.; Roda, A.; Roda, E. 2002: Pharmacokinetics and bioavailability of four modified-release ursodeoxycholic acid preparations for once-a-day administration International Journal of Clinical Pharmacology Research 22(2): 37-45
Pichler, M.; Brandt, D.; Teubl, H.; Dorda, W. 1995: Isosorbide-5-mononitrate in silent ischemia Wiener Klinische Wochenschrift 107(13): 390-395
Wood, S.G.; John, B.A.; Chasseaud, L.F.; Major, R.M.; Forrest, M.E.; Bonn, R.; Darragh, A.; Lambe, R.F. 1984: Metabolic fact of 14C-isosorbide 5-mononitrate in humans Arzneimittel-Forschung 34(9): 1031-1035
Coppi, G.; Borella, F.; Gatti, M.T.; Comini, A.; Dall' Asta, L. 1989: New isosorbide 5-mononitrate derivative with hypotensive activity Bollettino Chimico Farmaceutico 128(2): 74-76
Demin, A.A.; Aksenova, E.A. 2005: Efficacy of isosorbide-5-mononitrate retard in patients with stable exertional angina Klinicheskaia Meditsina 83(9): 53-56
Distante, A.; Lombardi, M.; Moscarelli, E.; Morales, M.A.; L'Abbate, A. 1986: The therapeutic role of isosorbide-5-mononitrate+ in stable and unstable angina pectoris Zeitschrift für Kardiologie 75(Suppl 3): 38-41
Hatanaka, A.R.; Moron, A.F.; Auxiliadora de Aquino, M.M.; de Souza, E.; de Silva Bussamra, L.C.; Araujo Júnior, E.; Mattar, R. 2012: Interruption of a study of cervical ripening with isosorbide mononitrate due to adverse effects Clinical and Experimental Obstetrics and Gynecology 39(2): 175-180